华法林给药剂量预测模型的建立与应用

[1] Warfarin and Other Coumarin Derivatives: Pharmacokinetics, Pharmacodynamics, and Drug Interactions[J] . Ann Wittkowsky. &nbspSeminars in Vascular Medicine . 2003 (03)

[2] Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues[J] . Brian F. Gage,Lawrence J. Lesko. &nbspJournal of Thrombosis and Thrombolysis . 2008 (1)

[3] 血浆蛋白C基因多态性与华法林剂量相关性的研究 [J]. 中国药学杂志, 2012, 47 (21) : 1741 - 1745

[4] 验证并比较华法林稳定剂量预测模型对中国心脏瓣膜置换术后患者预测准确性 [J]. 中国临床药理学与治疗学, 2012, 17 (09) : 1026 - 1033

[5] Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (11) : 1097 - 1103

[6] Vitamin K: A Practical Guide to the Dietary Management of Patients on Warfarin[J] . Sarah L.Booth,Maria A.Centurelli. &nbspNutrition Reviews . 2009 (9)

[7] Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients[J] . Sheng-Wen Huang,Hai-Sheng Chen,Xian-Qun Wang,Ling Huang,Ding-Li Xu,Xiao-Jia Hu,Zhi-Hui Huang,Yong He,Kai-Ming Chen,Dao-Kang Xiang,Xiao-Ming Zou,Qiang Li,Li-Qin Ma,Hao-Fei Wang,Bao-Lin Chen,Liang Li,Yan-Kai Jia,Xiang-Min Xu. &nbspPharmacogenetics and Genomics . 2009 (3)

[8] Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing. P Lenzini,M Wadelius,S Kimmel,J L Anderson,A L Jorgensen,M Pirmohamed,M D Caldwell,N Limdi,J K Burmester,M B Dowd,P Angchaisuksiri,A R Bass,J Chen,N Eriksson,A Rane,J D Lindh,J F Carlquist,B D Horne,G Grice,P E Milligan,C Eby,J Shin. Clinical Pharmacokinetics . 2010

[9] Prediction of warfarin dose: why, when and how?. Niclas Eriksson,Mia Wadelius. Pharmacogenomics . 2012

[10] Kidney function influences warfarin responsiveness and hemorrhagic complications. Limdi Nita A,Beasley T Mark,Baird Melissa F,Goldstein Joyce A,McGwin Gerald,Arnett Donna K,Acton Ronald T,Allon Michael. Journal of the American Society of Nephrology : JASN . 2009

[1] Warfarin and Other Coumarin Derivatives: Pharmacokinetics, Pharmacodynamics, and Drug Interactions[J] . Ann Wittkowsky. &nbspSeminars in Vascular Medicine . 2003 (03)

[2] Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues[J] . Brian F. Gage,Lawrence J. Lesko. &nbspJournal of Thrombosis and Thrombolysis . 2008 (1)

[3] 血浆蛋白C基因多态性与华法林剂量相关性的研究 [J]. 中国药学杂志, 2012, 47 (21) : 1741 - 1745

[4] 验证并比较华法林稳定剂量预测模型对中国心脏瓣膜置换术后患者预测准确性 [J]. 中国临床药理学与治疗学, 2012, 17 (09) : 1026 - 1033

[5] Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (11) : 1097 - 1103

[6] Vitamin K: A Practical Guide to the Dietary Management of Patients on Warfarin[J] . Sarah L.Booth,Maria A.Centurelli. &nbspNutrition Reviews . 2009 (9)

[7] Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients[J] . Sheng-Wen Huang,Hai-Sheng Chen,Xian-Qun Wang,Ling Huang,Ding-Li Xu,Xiao-Jia Hu,Zhi-Hui Huang,Yong He,Kai-Ming Chen,Dao-Kang Xiang,Xiao-Ming Zou,Qiang Li,Li-Qin Ma,Hao-Fei Wang,Bao-Lin Chen,Liang Li,Yan-Kai Jia,Xiang-Min Xu. &nbspPharmacogenetics and Genomics . 2009 (3)

[8] Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing. P Lenzini,M Wadelius,S Kimmel,J L Anderson,A L Jorgensen,M Pirmohamed,M D Caldwell,N Limdi,J K Burmester,M B Dowd,P Angchaisuksiri,A R Bass,J Chen,N Eriksson,A Rane,J D Lindh,J F Carlquist,B D Horne,G Grice,P E Milligan,C Eby,J Shin. Clinical Pharmacokinetics . 2010

[9] Prediction of warfarin dose: why, when and how?. Niclas Eriksson,Mia Wadelius. Pharmacogenomics . 2012

[10] Kidney function influences warfarin responsiveness and hemorrhagic complications. Limdi Nita A,Beasley T Mark,Baird Melissa F,Goldstein Joyce A,McGwin Gerald,Arnett Donna K,Acton Ronald T,Allon Michael. Journal of the American Society of Nephrology : JASN . 2009